These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 4028032)

  • 1. Aminoglutethimide-induced hematologic toxicity: worldwide experience.
    Messeih AA; Lipton A; Santen RJ; Harvey HA; Boucher AE; Murray R; Ragaz J; Buzdar AU; Nagel GA; Henderson IC
    Cancer Treat Rep; 1985 Sep; 69(9):1003-4. PubMed ID: 4028032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aminoglutethimide-induced leukopenia: a case report and review of the literature.
    Gez E; Sulkes A
    Oncology; 1984; 41(6):399-402. PubMed ID: 6504495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe leukopenia induced by aminoglutethimide.
    Kampel LJ; Kurman MR
    Cancer Treat Rep; 1984 Oct; 68(10):1277-8. PubMed ID: 6525598
    [No Abstract]   [Full Text] [Related]  

  • 4. Prediction of hematologic toxicity after radioimmunotherapy with (131)I-labeled anticarcinoembryonic antigen monoclonal antibodies.
    Juweid ME; Zhang CH; Blumenthal RD; Hajjar G; Sharkey RM; Goldenberg DM
    J Nucl Med; 1999 Oct; 40(10):1609-16. PubMed ID: 10520699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Irreversible thrombocytopenia following aminoglutethimide.
    Kissin MW; Kark AE
    Cancer Treat Rep; 1983 Sep; 67(9):849. PubMed ID: 6883365
    [No Abstract]   [Full Text] [Related]  

  • 6. Pancytopenia induced by aminoglutethimide in the treatment of breast cancer.
    Lawrence B; Santen RJ; Lipton A; Harvey HA; Hamilton R; Mercurio T
    Cancer Treat Rep; 1978 Oct; 62(10):1581-3. PubMed ID: 213192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cases of drug-induced blood disorders in Chugoku district].
    Hino N
    Rinsho Ketsueki; 1991 Jul; 32(7):714-7. PubMed ID: 1920832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leukopenia associated with aminoglutethimide therapy: a case report.
    Austerlitz J
    Cancer Treat Rep; 1982 Oct; 66(10):1879. PubMed ID: 7127328
    [No Abstract]   [Full Text] [Related]  

  • 9. Hematologic adverse effects of aminoglutethimide.
    Buzdar AU; Fraschini G; Blumenschein GR
    Ann Intern Med; 1984 Jan; 100(1):159. PubMed ID: 6691645
    [No Abstract]   [Full Text] [Related]  

  • 10. Aminoglutethimide-induced bone marrow injury. Report of a case and review of the literature.
    Young JA; Newcomer LN; Keller AM
    Cancer; 1984 Oct; 54(8):1731-3. PubMed ID: 6478412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Everolimus-induced hematologic changes in patients with metastatic breast cancer.
    Chen A; Chen L; Al-Qaisi A; Romond E; Awasthi M; Kadamyan-Melkumyan V; Massarweh S
    Clin Breast Cancer; 2015 Feb; 15(1):48-53. PubMed ID: 25199576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progress report on two clinical trials in women with advanced breast cancer. Trial I: tamoxifen versus tamoxifen plus aminoglutethimide. Trial II: aminoglutethimide in patients with prior tamoxifen exposure.
    Ingle JN; Green SJ; Ahmann DL; Edmonson JH; Nichols WC; Frytak S; Rubin J
    Cancer Res; 1982 Aug; 42(8 Suppl):3461s-3467s. PubMed ID: 7044529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombocytopenia after combination therapy with aminoglutethimide and tamoxifen: which drug is to blame?
    Ragaz J; Buskard N; Manji M
    Cancer Treat Rep; 1984; 68(7-8):1015-6. PubMed ID: 6744333
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hematologic disorders in acute alcoholism. Study of 27 chronic alcoholic patients hospitalized in a state of intoxication].
    Coste T; Gouffier E; Paraf A
    Sem Hop; 1972 Sep; 48(37):2427-32. PubMed ID: 4346778
    [No Abstract]   [Full Text] [Related]  

  • 15. [Drug-induced blood dyscrasias in Tohoku district].
    Fukuda M
    Rinsho Ketsueki; 1991 Jul; 32(7):725-8. PubMed ID: 1920835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cytopenias with dyshematopoiesis after hypoglycemic sulfamide treatment. Apropos of 3 cases].
    Perlemuter L; Hazard J; Dreyfus B; Farge B
    Sem Hop; 1971 Dec; 47(53):3079-85. PubMed ID: 4336339
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment of metastasizing breast cancer with aminoglutethimide].
    Kübböck J; Ludwig H; Aiginger P; Linkesch W; Pötzi P
    Acta Med Austriaca; 1982; 9(5-6):221-6. PubMed ID: 7164757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Transient bone marrow inhibition caused by aminoglutethimide].
    Tel W; van Lijf JH; ten Napel CH
    Ned Tijdschr Geneeskd; 1989 Jan; 133(3):126-8. PubMed ID: 2922066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aminoglutethimide after tamoxifen therapy in advanced breast cancer: M. D. Anderson Hospital experience.
    Buzdar AU; Powell KC; Blumenschein GR
    Cancer Res; 1982 Aug; 42(8 Suppl):3448s-3450s. PubMed ID: 7083209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe thrombocytopenia following the administration of aminoglutethimide.
    Katz ME
    Conn Med; 1984 Jul; 48(7):423-4. PubMed ID: 6467929
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.